JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 26, 2025
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
JW THERAP-B: 2024 Environmental, Social and Governance Report
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
JW THERAP-B: Next Day Disclosure Return
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF CHAIRMAN
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR CARTEYVA IN CHINA AS SECOND-LINE TREATMENT IN RELAPSED OR REFRACTORY ADULT LARGE B-CELL LYMPHOMA
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
JW THERAP-B: CHANGE OF AUDITOR
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION OF CARTEYVA IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MENTLE CELL LYMPHOMA
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024